To identify and/or validate whether the immune diseases and disorders potentially modulated by IL-21 are linked with Blimp-1 deficiency, we first subjected genes selected from ATAC-Seq for differential chromatin accessibility and RNA-Seq data for expression levels in CKO and control T cells to Ingenuity Pathway Analysis (IPA). The gene discussed is IL21; the disease is immune system disorder.